pneumocandin a(0) has been researched along with cilofungin in 2 studies
| Studies (pneumocandin a(0)) | Trials (pneumocandin a(0)) | Recent Studies (post-2010) (pneumocandin a(0)) | Studies (cilofungin) | Trials (cilofungin) | Recent Studies (post-2010) (cilofungin) |
|---|---|---|---|---|---|
| 19 | 0 | 3 | 83 | 1 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abruzzo, G; Balkovec, J; Bartizal, K; Hammond, M; Krupa, D; Nollstadt, K; Schmatz, D; Schwartz, R; Trainor, C; Vanmiddlesworth, F | 1 |
| Cleare, WJ; Hajdu, R; Kropp, H; Onishi, J; Sundelof, JG | 1 |
2 other study(ies) available for pneumocandin a(0) and cilofungin
| Article | Year |
|---|---|
In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Azoles; beta-Glucans; Candida albicans; Candidiasis; Echinocandins; Glucans; Kidney; Lethal Dose 50; Mice; Mice, Inbred DBA; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrans | 1992 |
Pharmacokinetics of L-671,329 in rhesus monkeys and DBA/2 mice.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Echinocandins; Female; Half-Life; Injections, Intravenous; Macaca mulatta; Male; Mice; Mice, Inbred DBA; Peptides; Peptides, Cyclic; Species Specificity; Structure-Activity Relationship | 1992 |